151 – 182 of 182
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2004
-
Mark
Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus - an additional mechanism to increased autoantigen load?
(
- Contribution to journal › Article
-
Mark
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis
(
- Contribution to journal › Article
-
Mark
Pseudovaskulit - förvillande lik systemisk vaskulit ... men kräver helt annan behandling
(
- Contribution to journal › Article
- 2003
-
Mark
The ACR nomenclature for CNS lupus revisited.
(
- Contribution to journal › Article
-
Mark
The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
(
- Contribution to journal › Article
-
Mark
Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency
(
- Contribution to journal › Article
-
Mark
Prevalence and clinical correlations of antibodies against six beta 2-glycoprotein-I-related peptides in the antiphospholipid syndrome
(
- Contribution to journal › Article
- 2002
-
Mark
High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
The complement systemin systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
The rate and pattern of organ damage in late onset systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality.
(
- Contribution to journal › Article
-
Mark
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans
(
- Contribution to journal › Article
- 2001
-
Mark
Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia
(
- Contribution to journal › Article
-
Mark
Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden
(
- Contribution to journal › Article
-
Mark
Heterogeneity of C1q autoantibodies in patients with low concentrations of circulating C1q
2001) 8th European Meeting on Complement in Human Disease In Molecular Immunology 38(2-3). p.109-109(
- Contribution to journal › Published meeting abstract
-
Mark
Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle
(
- Contribution to journal › Article
- 2000
-
Mark
Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis
(
- Contribution to journal › Article
-
Mark
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
(
- Contribution to journal › Article
-
Mark
No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19
(
- Contribution to journal › Article
-
Mark
Binding of immune complexes to erythrocyte CR1 (CD35): difference in requirement of classical pathway components and indication of alternative pathway-mediated binding in C2-deficiency
(
- Contribution to journal › Article
-
Mark
Novel roles of complement in systemic lupus erythematosus - Hypothesis for a pathogenetic vicious circle
(
- Contribution to journal › Article
- 1999
-
Mark
A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups
(
- Contribution to journal › Article
-
Mark
Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus
(
- Contribution to journal › Article
- 1997
-
Mark
Allvarlig biverkning av metotrexat vid reumatoid artrit. Glöm ej säkerhetsrutiner vid interkurrent sjukdom!
(
- Contribution to journal › Article
- 1996
-
Mark
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
- 1995
-
Mark
Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17]
(
- Contribution to journal › Article
- 1994
-
Mark
Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations
(
- Contribution to journal › Article
- 1993
-
Mark
Antiproliferative effects on human peripheral blood mononuclear cells and inhibition of in vitro immunoglobulin synthesis by Podophyllotoxin (CPH86) and by semisynthetic lignan glycosides (CPH82)
(
- Contribution to journal › Article
- 1988
-
Mark
Inhibition of ConA-induced proliferative response in human lymphocytes by podophyllotoxin and a detergent, Tween80
(
- Contribution to journal › Article
- 1985
-
Mark
Serum Concentration of Cystatin C, Factor D and β2‐Microglobulin as a Measure of Glomerular Filtration Rate
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »